På baggrund af det "proof- of- principle", der fandt anvendelse på alle immunoglobuliner, fandt BPWP, at det var acceptabelt at indsende en enkelt farmakokinetisk undersøgelse.
Based on the proof-of-principle applied to all immunoglobulins, the BPWP considered that submitting a single PK study is acceptable.